About the department
The Department of Molecular and Clinical Cancer Medicine (DMCCM) is one of six departments within the Institute of Translational Medicine (ITM) and is a key component of the North West Cancer Research Centre – University of Liverpool.
The Department of Molecular and Clinical Cancer Medicine provides a vibrant home to approximately 200 staff including 30 principle investigators who collectively lead a comprehensive programme of basic, translational and clinical cancer research. Clinical focus areas include pancreas cancer, ocular oncology, lung cancer, head and neck cancer, hepatobiliary cancer, haematological oncology, urological cancer and breast cancer while areas of particular scientific strength include DNA repair, p53 biology and tumour microenvironment.
The Department hosts several important underpinning structures including the Cancer Research UK Liverpool Cancer Trials Unit (LCTU), the Liverpool Early Drug Development Unit (LEDDU), the Liverpool Tissue Bank (LTB), the GCLP Laboratory and the NIHR Pancreas Biomedical Research Unit (PBRU).
Postgraduate students of the Department receive high quality training and produce high quality research in a wide range of cancer-related disciplines.
Our key research areas are:-